During the past decade, Hematology-Oncology & SCT Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology-Oncology & SCT Research Center" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hematology-Oncology & SCT Research Center" are "Bone Marrow Transplantation" (2 trials), "Leukemia, Myeloid, Chronic" (2 trials), "Mucositis" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Beta-Thalassemia" (1 trials). Many other conditions were trialed in "Hematology-Oncology & SCT Research Center" in a lesser frequency.

Most popular intervention types in "Hematology-Oncology & SCT Research Center" are "Drug" (6 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation" (1 trials), "Allogeneic bone marrow transplantation" (1 trials), "Autologous bone marrow transplantation" (1 trials) and "Bcr-abl multipeptide vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology-Oncology & SCT Research Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hematology-Oncology & SCT Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hematology-Oncology & SCT Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hematology-Oncology & SCT Research Center, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".